Cernostics Contracts with Geisinger Health Plan to Become an In-network Provider for TissueCypher® Barrett’s Esophagus Assay
08. September 2021 09:00 ET
|
Cernostics
Pittsburgh, PA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Cernostics, pioneer of the worlds’ first precision medicine test to predict future development risk of esophageal cancer from Barrett’s esophagus...